Cizzle Biotechnology Holdings (CIZ)

Sector:

Pharma and Biotech

1.47p
   
  • Change Today:
    -0.18p
  • 52 Week High: 2.30
  • 52 Week Low: 1.45
  • Currency: UK Pounds
  • Shares Issued: 396.39m
  • Volume: 169,802
  • Market Cap: £5.81m
  • Beta: 0.05

CIZ Overview

Cizzle Biotechnology is a spin-out from the University of York and is a biotechnology business focused on the early detection of Lung cancer via the development of an immunoassay test for the CIZ1B biomaker. Cizzle Biotechnology was initially funded by Yorkshire Cancer Research, White Rose Technology Seed Corn Fund, Finance Yorkshire Seedcorn LLP and Viking Members, who with management, invested in the project to support the development of a prototype blood test.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 4.3  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

CIZ Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 n/a (0.83) n/a n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (0.01) (2.80)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (3.96) (2.40)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (0.96) (0.30)p n/a n/a n/a n/a 0.0%
31-Dec-23 n/a (1.76) (0.50)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

CIZ Company Announcements

Appointment of Non-Executive Director 25-Mar-2025 07:00 RNS
Update on Launch of CIZ1B Biomarker Assay 24-Mar-2025 07:00 RNS
Appointment of Professor Dawn Coverley as CSO 02-Jan-2025 07:00 RNS

CIZ ShareCast News

No recent information was found.

Latest CIZ Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

CIZ Market Data

Currency UK Pounds
Share Price 1.47p
Change Today -0.18p
% Change -11.11 %
52 Week High 2.30
52 Week Low 1.45
Volume 169,802
Shares Issued 396.39m
Market Cap £5.81m
Beta 0.05

CIZ Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.26% below the market average30.26% below the market average30.26% below the market average30.26% below the market average30.26% below the market average
27.66% below the sector average27.66% below the sector average27.66% below the sector average27.66% below the sector average27.66% below the sector average
Price Trend
49.69% below the market average49.69% below the market average49.69% below the market average49.69% below the market average49.69% below the market average
2.04% below the sector average2.04% below the sector average2.04% below the sector average2.04% below the sector average2.04% below the sector average
Income Not Available
Growth Not Available

CIZ Dividends

No dividends found

Trades for 31-Mar-2025

Time Volume / Share Price
13:41 32,467 @ 1.54p
13:23 19,060 @ 1.54p
12:50 10,000 @ 1.55p
12:49 42,500 @ 1.51p
12:10 63,000 @ 1.57p

CIZ Key Personnel

Finance Director Nigel Ronald Lee

Top of Page